Protease activated receptor-1 deficiency diminishes bleomycin-induced skin fibrosis

Molecular Medicine

Volumn 20, Issue JULY-DECEMBER 2014, 2014, Pages 410-416

  Peppelenbosch, Maikel P ^d   Florquin, Sandrine ^b   Shi, Kun ^a   Arnold Spek, C ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c INSERM   (France)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; COLLAGEN; FIBRONECTIN; PROTEINASE ACTIVATED RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN FIBROBLAST; SKIN FIBROSIS; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CELL LINE; CHEMICALLY INDUCED; DRUG EFFECTS; FIBROBLAST; FIBROSIS; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SKIN; SKIN DISEASE;

ANIMALS; BLEOMYCIN; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; HUMANS; KERATINOCYTES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, PAR-1; SKIN; SKIN DISEASES;

EID: 84919687686     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2014.00027     Document Type: Article

References (23)

1. Gabrielli A, Svegliati S, Moroncini G, Amico D. (2012) New insights into the role of oxidative stress in scleroderma fibrosis. Open Rheumatol. J. 6:87–95.
2. Shaw TJ, Kishi K, Mori R. (2010) Wound-associated skin fibrosis: mechanisms and treatments based on modulating the inflammatory response. Endocr. Metab. Immune Disord. Drug Targets. 10:320–30.
3. Canady J, Karrer S, Fleck M, Bosserhoff AK. (2013) Fibrosing connective tissue disorders of the skin: Molecular similarities and distinctions. J. Dermatol. Sci. 70:151–8.
4. Gilbane AJ, Denton CP, Holmes AM. (2013) Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells. Arthritis Res. Ther. 15:215–23.
5. Leask A, Abraham DJ. (2004) TGF-beta signaling and the fibrotic response. FASEB J. 18:816–27.
6. Vu TKH, Hung DT, Wheaton VI, Coughlin SR. (1991) Molecular-cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64:1057–68.
7. Ramachandran R, Hollenberg M. (2008) Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br. J. Pharmacol. 153:S263–82.
8. Lin C, et al. (2014) Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis. Thorax. 69:152–60.
9. Howell DCJ, et al. (2005) Absence of proteinaseactivated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am. J. Pathol. 166:1353–65.
10. Rullier A, et al. (2008) Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 294:G226-35.
11. Cevikbas F, et al. (2011) Role of protease-activated receptors in human skin fibrosis and scleroderma. Exp. Dermatol. 20:69–71.
12. Materazzi S, et al. (2007) Analysis of proteaseactivated receptor-1 and-2 in human scar formation. J. Pathol. 212:440–9.
13. Strukova SM, et al. (2001) Immobilized thrombin receptor agonist peptide accelerates wound healing in mice. Clin. Appl. Thromb. Hemost. 7:325–9.
14. Connolly AJ, Ishihara H, Kahn ML, Farese RV, Coughlin SR. (1996) Role of the thrombin receptor In development and evidence for a second receptor. Nature. 381:516–9.
15. Schouten M, van’t Veer C, Roelofs JJ, Levi M, van der Poll T. (2012) Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study. Crit. Care. 16:R238.
16. Bijlsma MF, et al. (2008) Endogenous hedgehog expression contributes to myocardial ischemiareperfusion- induced injury. Exp. Biol. Med. (Maywood). 233:989–96.
17. Duitman J, et al. (2014) CCAAT-enhancer binding protein delta (C/EBPdelta) attenuates tubular injury and tubulointerstitial fibrogenesis during chronic obstructive nephropathy. Lab. Invest. 94:89–97.
18. Anastasov N, et al. (2009) Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer. J. Hematop. 2:9–19.
19. Duitman J, et al. (2012) CCAAT/enhancer-binding protein delta facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent manner. Proc. Natl. Acad. Sci. U. S. A. 109:9113–8.
20. Yamamoto T, Takagawa S, Katayama I, Nishioka E. (1999) Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma. Clin. Immunol. 92:6–13.
21. Ravanti L, et al. (2001) Expression of human collagenase- 3 (MMP-13) by fetal skin fibroblasts is induced by transforming growth factor-beta via p38 mitogen-activated protein kinase. FASEB J. 15:1098–100.
22. Komatsu N, et al. (2003) Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages. J. Invest. Dermatol. 121:542–9.
23. Vorstenbosch J, et al. (2013) CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma. Arthritis Rheum. 65:1378–83.